| Q36545127 | A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness. |
| Q99586414 | A disintegrin and metalloproteinase 8 induced epithelial-mesenchymal transition to promote the invasion of colon cancer cells via TGF-β/Smad2/3 signalling pathway |
| Q35357838 | A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-β1-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells |
| Q48134448 | A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells |
| Q36316820 | AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition |
| Q39123818 | APRIL depletion induces cell cycle arrest and apoptosis through blocking TGF-β1/ERK signaling pathway in human colorectal cancer cells |
| Q34269750 | Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway |
| Q92366814 | Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in non‑small cell lung cancer |
| Q35128650 | Apoptosis, autophagy, necroptosis, and cancer metastasis |
| Q38989374 | Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview |
| Q38093337 | Aptamers and their potential to selectively target aspects of EGF, Wnt/β-catenin and TGFβ-smad family signaling |
| Q49385083 | Ascending the PEAK1 toward targeting TGFβ during cancer progression: Recent advances and future perspectives |
| Q36299382 | Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer |
| Q48834589 | Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D. |
| Q53240350 | Basonuclin-1 modulates epithelial plasticity and TGF-β1-induced loss of epithelial cell integrity. |
| Q51354400 | Benzophenone-3 increases metastasis potential in lung cancer cells via epithelial to mesenchymal transition. |
| Q34629931 | Beta-elemene blocks epithelial-mesenchymal transition in human breast cancer cell line MCF-7 through Smad3-mediated down-regulation of nuclear transcription factors |
| Q26752755 | Biomarkers and Targeted Therapy in Pancreatic Cancer |
| Q34769289 | C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer |
| Q90198252 | CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway |
| Q91620382 | CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling |
| Q59358229 | Cancer Progression Goes Viral: The Role of Oncoviruses in Aggressiveness of Malignancies |
| Q38184909 | Cancer Systems Biology: a peek into the future of patient care? |
| Q35664216 | Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ |
| Q36967911 | Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model |
| Q47313215 | Comprehensive bioinformation analysis of the miRNA of PLCE1 knockdown in esophageal squamous cell carcinoma |
| Q37640196 | Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer |
| Q93161614 | CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling |
| Q92956445 | DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma |
| Q26738556 | DNA Repair and Cytokines: TGF-β, IL-6, and Thrombopoietin as Different Biomarkers of Radioresistance |
| Q38740937 | Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β |
| Q64897697 | Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer. |
| Q52928162 | Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development. |
| Q26744487 | Export of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring Cells |
| Q36867012 | Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway |
| Q35154337 | FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer |
| Q96953242 | Flaming the fight against cancer cells: the role of microRNA-93 |
| Q36729546 | GDF15 promotes EMT and metastasis in colorectal cancer |
| Q33688954 | Gambogic acid suppresses cancer invasion and migration by inhibiting TGFβ1-induced epithelial-to-mesenchymal transition |
| Q36015571 | Genetic Polymorphisms of TGFB1, TGFBR1, SNAI1 and TWIST1 Are Associated with Endometrial Cancer Susceptibility in Chinese Han Women |
| Q36946716 | Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites |
| Q50154920 | Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis |
| Q37554525 | Global Prioritizing Disease Candidate lncRNAs via a Multi-level Composite Network |
| Q92512101 | HEY2 acting as a co-repressor with smad3 and smad4 interferes with the response of TGF-beta in hepatocellular carcinoma |
| Q38969822 | HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells |
| Q47133697 | Hispolon as an inhibitor of TGF-β-induced epithelial-mesenchymal transition in human epithelial cancer cells by co-regulation of TGF-β-Snail/Twist axis |
| Q92705398 | Hitting More Birds with a Stone: Impact of TGF-β on ILC Activity in Cancer |
| Q35037258 | Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer. |
| Q39037011 | In silico identification of potential therapeutic targets in the TGF-β signal transduction pathway. |
| Q91671992 | Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-β from growth suppressor to growth and metastasis promoter through TMEPAI/PMEPA1 in triple negative breast cancer |
| Q42432514 | Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis |
| Q38799898 | Inflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-β1. |
| Q92448089 | Inhibition of TGF-β Signaling in Gliomas by the Flavonoid Diosmetin Isolated from Dracocephalum peregrinum L |
| Q36946688 | Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling |
| Q49702140 | Inhibition of overactive TGF-β attenuates progression of heterotopic ossification in mice. |
| Q92618172 | Inhibition of the TGF-β/Smads signaling pathway attenuates pulmonary fibrosis and induces anti-proliferative effect on synovial fibroblasts in rheumatoid arthritis |
| Q92382522 | Insight into the effects of microRNA-23a-3p on pancreatic cancer and its underlying molecular mechanism |
| Q33610627 | Integrin β1 activation induces an anti-melanoma host response |
| Q38846848 | Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway |
| Q36924111 | LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells |
| Q49083521 | Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2. |
| Q55502394 | Liver regeneration accelerates hepatitis B virus-related tumorigenesis of hepatocellular carcinoma. |
| Q33568760 | Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway |
| Q47138075 | Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions |
| Q23909988 | MDSC and TGFβ are required for facilitation of tumor growth in the lungs of mice exposed to carbon nanotubes |
| Q38694277 | MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer |
| Q90400264 | MFAP2 promotes epithelial-mesenchymal transition in gastric cancer cells by activating TGF-β/SMAD2/3 signaling pathway |
| Q41949154 | MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. |
| Q36678754 | MicroRNAs for Fine-Tuning of Mouse Embryonic Stem Cell Fate Decision through Regulation of TGF-β Signaling. |
| Q49379553 | Microenvironment‑driven resistance to B‑Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts |
| Q38301071 | Molecular Mechanism of Activation of Transforming Growth Factor Beta/Smads Signaling Pathway in Ets Related Gene-Positive Prostate Cancers |
| Q26999345 | Molecular mechanism underlying lymphatic metastasis in pancreatic cancer |
| Q49594691 | NF-κB, inflammation, immunity and cancer: coming of age. |
| Q26764831 | New Insights into the Crossroads between EMT and Stemness in the Context of Cancer |
| Q89528234 | New landscapes and horizons in hepatocellular carcinoma therapy |
| Q39010093 | Nucleolin promotes TGF-β signaling initiation via TGF-β receptor I in glioblastoma |
| Q102075450 | O-GlcNAc stabilizes SMAD4 by inhibiting GSK-3β-mediated proteasomal degradation |
| Q100533933 | OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer |
| Q37217722 | OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3. |
| Q33889211 | OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis. |
| Q28296317 | Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis |
| Q42217653 | Orf virus IL-10 accelerates wound healing while limiting inflammation and scarring |
| Q52978477 | Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. |
| Q58699735 | PARP12 (ARTD12) suppresses hepatocellular carcinoma metastasis through interacting with FHL2 and regulating its stability |
| Q38988131 | PLCγ1-PKCγ signaling-mediated Hsp90α plasma membrane translocation facilitates tumor metastasis. |
| Q39666911 | Parenchyma-stromal interactions induce fibrosis by secreting CCN2 and promote osteoclastogenesis by stimulating RANKL and CD68 through activated TGF-β/BMP4 in ameloblastoma |
| Q63247265 | Perioperative red blood cell transfusion in orofacial surgery |
| Q37649636 | Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas |
| Q34652408 | Plasticity of γδ T Cells: Impact on the Anti-Tumor Response |
| Q91620425 | Plug-and-Play In Vitro Metastasis System toward Recapitulating the Metastatic Cascade |
| Q60938672 | Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases |
| Q57115094 | Profiles of Radioresistance Mechanisms in Prostate Cancer |
| Q37606662 | Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment |
| Q33734780 | Regulation of tumor growth and metastasis: the role of tumor microenvironment |
| Q92042963 | Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer |
| Q28066950 | Role of Akt signaling in resistance to DNA-targeted therapy |
| Q50586476 | Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer. |
| Q51109576 | SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis. |
| Q42147799 | STAT3 selectively interacts with Smad3 to antagonize TGF-β |
| Q92859971 | Salt-inducible kinases (SIKs) regulate TGFβ-mediated transcriptional and apoptotic responses |
| Q90521213 | Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma |
| Q38751721 | Siegesbeckia orientalis Extract Inhibits TGFβ1-Induced Migration and Invasion of Endometrial Cancer Cells. |
| Q53238642 | Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer. |
| Q92541727 | Silencing of Long Non-coding RNA SMAD5-AS1 Reverses Epithelial Mesenchymal Transition in Nasopharyngeal Carcinoma via microRNA-195-Dependent Inhibition of SMAD5 |
| Q41485074 | TGF Beta1 Expression Correlates with Survival and Tumor Aggressiveness of Prostate Cancer |
| Q38960321 | TGF-beta induced RBL2 expression in renal cancer cells by down-regulating miR-93. |
| Q39129165 | TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer |
| Q90926980 | TGF-β Family Signaling Pathways in Cellular Dormancy |
| Q28076815 | TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression |
| Q92012224 | TGF-β and microRNA Interplay in Genitourinary Cancers |
| Q59791111 | TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade |
| Q37100262 | TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. |
| Q41550102 | TGF-β participates choroid neovascularization through Smad2/3-VEGF/TNF-α signaling in mice with Laser-induced wet age-related macular degeneration |
| Q58586393 | TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure |
| Q36737131 | TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis |
| Q83600789 | TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p |
| Q38955929 | TGF-β1 mediates the radiation response of prostate cancer |
| Q50431861 | TGF-β1 regulates the expression and transcriptional activity of TAZ protein via a Smad3-independent, myocardin-related transcription factor-mediated mechanism |
| Q35144872 | TGFBI protein high expression predicts poor prognosis in colorectal cancer patients |
| Q28075605 | TGFΒ-induced transcription in cancer |
| Q38833693 | TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways |
| Q39155944 | TGFβ signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders |
| Q35098665 | TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells |
| Q90410019 | TIM-3 Participates in the Invasion and Metastasis of Nasopharyngeal Carcinoma via SMAD7/SMAD2/SNAIL1 Axis-Mediated Epithelial-Mesenchymal Transition |
| Q39441327 | Targeting TGF-β Signaling in Cancer |
| Q35181108 | Targeting cancer stem cells in solid tumors by vitamin D. |
| Q38600094 | Targeting the Wnt signaling pathway in colorectal cancer |
| Q42590775 | Targeting the transforming growth factor (TGF)-β cascade in the remodeling heart: benefits and perils |
| Q48590220 | The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis |
| Q38946786 | The Downregulation of MicroRNA-146a Modulates TGF-β Signaling Pathways Activity in Glioblastoma |
| Q42154608 | The HPV16 E6 oncoprotein and UVB irradiation inhibit the tumor suppressor TGFβ pathway in the epidermis of the K14E6 transgenic mouse |
| Q98178433 | The Post-translational Modifications of Smurf2 in TGF-β Signaling |
| Q40996773 | The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells |
| Q91791041 | The TGFβ1-FOXM1-HMGA1-TGFβ1 positive feedback loop increases the cisplatin resistance of non-small cell lung cancer by inducing G6PD expression |
| Q94563647 | The double-edged sword role of fibroblasts in the interaction with cancer cells; an agent-based modeling approach |
| Q38227721 | The emerging roles of deubiquitylating enzymes (DUBs) in the TGFβ and BMP pathways |
| Q35633748 | The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling. |
| Q33890223 | The production of fibroblast growth factor 23 is controlled by TGF-β2. |
| Q33857612 | The regulation of TGF-β/SMAD signaling by protein deubiquitination |
| Q37419709 | The role of epithelial mesenchymal transition markers in thyroid carcinoma progression. |
| Q64950163 | The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy. |
| Q38185910 | The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review). |
| Q26778983 | Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer |
| Q39645601 | Transcriptome Alterations In X-Irradiated Human Gingiva Fibroblasts |
| Q58754397 | Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis |
| Q38132176 | Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer |
| Q58767650 | Transforming growth factor-β signaling in head and neck squamous cell carcinoma: Insights into cellular responses |
| Q37596473 | Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3 |
| Q35867960 | Transforming growth factor-β1 requires NADPH oxidase 4 for angiogenesis in vitro and in vivo |
| Q39367491 | Transfusion-related immunomodulation and cancer |
| Q28067674 | Trends and advances in tumor immunology and lung cancer immunotherapy |
| Q39507240 | Up-regulated expression of phospholipase C, β1 is associated with tumor cell proliferation and poor prognosis in hepatocellular carcinoma |
| Q55154175 | Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients. |
| Q53410584 | Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. |
| Q33730462 | hrHPV E5 oncoprotein: immune evasion and related immunotherapies. |
| Q37688919 | miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway |
| Q55310838 | miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer. |